| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/CHEM.201704861 |
| P698 | PubMed publication ID | 29178467 |
| P50 | author | Lorena García-Hevia | Q41634198 |
| Juan Gallo | Q43138446 | ||
| Manuel Bañobre-López | Q57064194 | ||
| P2093 | author name string | Francisco Rivadulla | |
| M Fatima Cerqueira | |||
| P2860 | cites work | Potential dual imaging nanoparticle: Gd2O3 nanoparticle. | Q30898107 |
| A gadolinium chelate for detection of beta-glucuronidase: a self-immolative approach | Q31004514 | ||
| The synthesis and in vitro testing of a zinc-activated MRI contrast agent | Q31122779 | ||
| Towards extracellular Ca2+ sensing by MRI: synthesis and calcium-dependent 1H and 17O relaxation studies of two novel bismacrocyclic Gd3+ complexes | Q31129489 | ||
| An overview of responsive MRI contrast agents for molecular imaging | Q31135349 | ||
| A R2/R1 ratiometric procedure for a concentration-independent, pH-responsive, Gd(III)-based MRI agent | Q33255681 | ||
| Synthesis of uniform hollow oxide nanoparticles through nanoscale acid etching | Q33430369 | ||
| Activatable T₁ and T₂ magnetic resonance imaging contrast agents | Q33823740 | ||
| Hydrogen peroxide fuels aging, inflammation, cancer metabolism and metastasis: the seed and soil also needs "fertilizer". | Q35232552 | ||
| Photochromically-controlled, reversibly-activated MRI and optical contrast agent | Q36915811 | ||
| Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis | Q36985258 | ||
| Glutathione in cancer cell death | Q37129883 | ||
| Synthesis and characterization of a redox- and light-sensitive MRI contrast agent | Q37183401 | ||
| Synthesis and relaxometric studies of a dendrimer-based pH-responsive MRI contrast agent. | Q37378003 | ||
| Responsive magnetic resonance imaging contrast agents as chemical sensors for metals in biology and medicine | Q37659916 | ||
| Role of glutathione in cancer progression and chemoresistance | Q38114436 | ||
| Magnetic nanoparticles as contrast agents in the diagnosis and treatment of cancer. | Q38115981 | ||
| Environmentally responsive MRI contrast agents | Q38138098 | ||
| Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery | Q39911191 | ||
| Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles | Q40159671 | ||
| Proteolytic actuation of nanoparticle self-assembly | Q40286980 | ||
| Activatable magnetic resonance imaging agent reports myeloperoxidase activity in healing infarcts and noninvasively detects the antiinflammatory effects of atorvastatin on ischemia-reperfusion injury. | Q41864110 | ||
| CXCR4-targeted and MMP-responsive iron oxide nanoparticles for enhanced magnetic resonance imaging | Q43138300 | ||
| A comparison study on Raman scattering properties of alpha- and beta-MnO2. | Q45971115 | ||
| Green synthesis of multimodal 'OFF-ON' activatable MRI/optical probes. | Q48971092 | ||
| A rapid fluorescence "switch-on" assay for glutathione detection by using carbon dots-MnO2 nanocomposites | Q50979320 | ||
| Break-up of two-dimensional MnO2 nanosheets promotes ultrasensitive pH-triggered theranostics of cancer. | Q53465222 | ||
| A smart DNAzyme-MnO₂ nanosystem for efficient gene silencing. | Q55066582 | ||
| A tumor-environment-responsive nanocarrier that evolves its surface properties upon sensing matrix metalloproteinase-2 and initiates agglomeration to enhance T₂ relaxivity for magnetic resonance imaging | Q57184908 | ||
| Development of aT1 Contrast Agent for Magnetic Resonance Imaging Using MnO Nanoparticles | Q57258926 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | contrast agent | Q6849688 |
| P304 | page(s) | 1295-1303 | |
| P577 | publication date | 2017-11-27 | |
| P1433 | published in | Chemistry—A European Journal | Q898737 |
| P1476 | title | Tunable Performance of Manganese Oxide Nanostructures as MRI Contrast Agents. | |
| P478 | volume | 24 |
| Q55339815 | pH-responsive theranostic nanocomposites as synergistically enhancing positive and negative magnetic resonance imaging contrast agents. | cites work | P2860 |
Search more.